Literature DB >> 24602954

The effectiveness of routine daily chlorhexidine gluconate bathing in reducing Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae skin burden among long-term acute care hospital patients.

Michael Y Lin1, Karen Lolans, Donald W Blom, Rosie D Lyles, Shayna Weiner, Kavya B Poluru, Nicholas Moore, David W Hines, Robert A Weinstein, Mary K Hayden.   

Abstract

We evaluated the effectiveness of daily chlorhexidine gluconate (CHG) bathing in decreasing skin carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae (KPC) among long-term acute care hospital patients. CHG bathing reduced KPC skin colonization, particularly when CHG skin concentrations greater than or equal to 128 μg/mL were achieved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24602954     DOI: 10.1086/675613

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  17 in total

1.  What's new in the prevention of healthcare-associated infections using chlorhexidine gluconate-impregnated washcloths.

Authors:  Sandrine Dray; Jean-Marie Forel; Laurent Papazian
Journal:  Intensive Care Med       Date:  2018-11-26       Impact factor: 17.440

2.  Emergence of carbapenem-resistant Enterobacteriaceae in Orange County, California, and support for early regional strategies to limit spread.

Authors:  Shruti K Gohil; Raveena Singh; Justin Chang; Adrijana Gombosev; Tom Tjoa; Matthew Zahn; Patti Steger; Susan S Huang
Journal:  Am J Infect Control       Date:  2017-07-27       Impact factor: 2.918

3.  Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial.

Authors:  Susan S Huang; Edward Septimus; Ken Kleinman; Julia Moody; Jason Hickok; Lauren Heim; Adrijana Gombosev; Taliser R Avery; Katherine Haffenreffer; Lauren Shimelman; Mary K Hayden; Robert A Weinstein; Caren Spencer-Smith; Rebecca E Kaganov; Michael V Murphy; Tyler Forehand; Julie Lankiewicz; Micaela H Coady; Lena Portillo; Jalpa Sarup-Patel; John A Jernigan; Jonathan B Perlin; Richard Platt
Journal:  Lancet       Date:  2019-03-05       Impact factor: 79.321

Review 4.  Preventing Transmission of Multidrug-Resistant Pathogens in the Intensive Care Unit.

Authors:  Jeffrey R Strich; Tara N Palmore
Journal:  Infect Dis Clin North Am       Date:  2017-07-05       Impact factor: 5.982

5.  The impact of chlorhexidine gluconate on the skin microbiota of children and adults: A pilot study.

Authors:  Ashley E Kates; Michele L Zimbric; Kaitlin Mitchell; Joseph Skarlupka; Nasia Safdar
Journal:  Am J Infect Control       Date:  2019-03-15       Impact factor: 2.918

6.  Insights into bacterial colonization of intensive care patients' skin: the effect of chlorhexidine daily bathing.

Authors:  N Cassir; L Papazian; P-E Fournier; D Raoult; B La Scola
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-22       Impact factor: 3.267

7.  A Descriptive Study of Chlorhexidine as a Disinfectant in Cleft Palate Surgery.

Authors:  Gieljam Johannes Roode; Kurt-Wilhelm Bütow
Journal:  Clin Med Res       Date:  2018-05-03

Review 8.  Decolonization in Prevention of Health Care-Associated Infections.

Authors:  Edward J Septimus; Marin L Schweizer
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

9.  Impact of preoperative chlorhexidine gluconate (CHG) application methods on preoperative CHG skin concentration.

Authors:  Bobby G Warren; Alicia Nelson; David K Warren; Meghan A Baker; Candace Miller; Tracey Habrock; Jahnavi Bongu; Abinav Gowda; Jacob Johnson; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2020-09-30       Impact factor: 3.254

Review 10.  Assessing the Potential for Unintended Microbial Consequences of Routine Chlorhexidine Bathing for Prevention of Healthcare-associated Infections.

Authors:  Ahmed Babiker; Joseph D Lutgring; Scott Fridkin; Mary K Hayden
Journal:  Clin Infect Dis       Date:  2021-03-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.